ANA and Jazz Pharmaceuticals Collaborate to Promote Sodium Reduction and Cardiovascular Health Education

The American Nutrition Association has partnered with Jazz Pharmaceuticals to advance evidence-based sodium reduction and cardiovascular health education, particularly for patients with narcolepsy or idiopathic hypersomnia, who have disproportionately higher cardiovascular and cardiometabolic comorbidities. The joint initiative aims to provide scientific validation and patient empowerment through credible, science-backed resources. The partnership aims to translate the latest nutrition science into actionable guidance for patients and healthcare providers to mitigate cardiovascular risk.